Food and Drug Administration Research — CFDA 93.103

FDA-research obligations at $1.66 billion

USAspending.gov records about $1.7 billion — $1,660,776,872.10 in obligations under CFDA 93.103. Eight hundred eighty awards produce that stock. A simple average is about $1.89 million per award — consistent with cooperative research awards rather than a single FDA appropriation line. That average is a quotient of two packet totals, not a typical lab budget or a per-study cost.

The assistance-listing title is FOOD AND DRUG ADMINISTRATION RESEARCH. CFDA 93.103 is the identifier. Other FDA user-fee or inspection listings tagged under different CFDA numbers are not mixed into the $1.66 billion. Combining those codes would invent a combined FDA total this packet does not contain.

346 recipients across 52 states

Three hundred forty-six recipients share 880 awards, or about 2.5 award records per recipient on average. Splitting $1.66 billion evenly would assign about $4.80 million per recipient. That pattern is a broad research-partner roster with a few repeat rows per named organization. The packet does not list the 346. Recipient count is the organizational headcount, not a census of investigators or products reviewed.

Fifty-two states in the geographic count is a near-complete map plus extra jurisdictions. FDA-research dollars in this extract follow that coded geography. Place-of-performance amounts are on the program table.

Eight hundred eighty awards on 346 recipients is a mid-repeat research-partner file, about 2.5 rows per organization. Fifty-two states in the geographic count is a near-complete map plus extra jurisdictions. The $1,660,776,872.10 obligation stock is not a product-approval log, not an inspection file, and not an FDA user-fee series. Those streams use other codes or non-assistance tables. Quote 880 as assistance rows and 346 as named organizations. About $1.89 million per award is cooperative-research scale on this packet.

Award count is not a study count

Among HHS assistance listings, 93.103 is a mid-volume file: 880 rows against 346 recipients. Competing renewals and cooperative-agreement years can inflate award count relative to unique partners. Award count is therefore a weak proxy for “number of research projects.” Recipients (346) tell you how many named organizations sit on the extract; awards (880) tell you how many assistance rows were stored.

The packet does not report publications, inspections, or product approvals. Citing 880 as studies would be a unit error. Keep the units straight: dollars, awards, recipients, states.

Obligations versus payment outlays

The $1.66 billion is an obligation total from USAspending.gov. Outlays — cash paid against FDA research awards — are not in the packet. A partner can show a large obligation stock while a draw follows a later budget period. Deobligations and upward adjustments both move the total. A remaining-balance question is an outlay question this extract does not answer.

Use CFDA 93.103 to size this Food and Drug Administration Research listing in the assistance file. Do not use it as an FDA user-fee, inspection, or NIH dashboard. Those series live elsewhere. This page reports the obligation book tagged 93.103.

What the 93.103 tables omit

The FDA Research hub lists award-backed obligations from USAspending.gov. It is not a product-approval log, not an inspection file, and not a publication index. Series that never appear as assistance awards will not show up in the $1,660,776,872.10. That omission is definitional rather than a gap in the 880 award rows.

Place-of-performance on 52 states is a coding field. Read the program page before treating those cells as equal shares. Recipient dollars, if shown on the hub, are still obligation amounts, not cash already spent on research.

Where the 93.103 table lives

The program page overlays these four facts. The all-programs index ranks 93.103 among other assistance listings. Agency pages show awarding-agency rollups that may include this CFDA among other HHS listings. For 93.103 only, start on the program page.

CFDA 93.103’s 880 awards spread $1,660,776,872.10 across 346 recipients and 52 states. Quote award count as a record count, recipient count as the organizational headcount, and dollars as obligations from USAspending.gov. About 2.5 award records per recipient is the density story on this listing. Outlays remain a separate column. Source: USAspending.gov assistance awards.

Questions

How much is obligated for FDA research?

USAspending.gov records $1,660,776,872.10 in obligations for CFDA 93.103. SpendingVault indexes 880 awards, 346 recipients, and 52 states. The figure is an obligation sum from assistance awards, not an outlay and not a study count. CFDA 93.103’s $1.66 billion is the USAspending obligation stock.

How many awards does CFDA 93.103 carry?

The listing shows 880 awards against 346 recipients, or about 2.5 award records per recipient. A simple average is about $1.89 million per award. Award count is not a product-review or inspection count. Recipient dollars are on the program page.

How many organizations receive 93.103 awards?

The extract lists 346 recipients. Those are organizational recipients on assistance awards tagged 93.103. Geographic coding covers 52 states. The packet does not name the 346 or publish study counts. Recipient count is the organizational headcount. USAspending.gov indexes those rows as assistance obligations, not outlays.

Is $1.66 billion already paid to FDA research partners?

Not necessarily. Obligations are commitments. Outlays are payments. CFDA 93.103’s indexed total is the obligation stock from USAspending.gov. This page does not report cash drawn, remaining balances, or publications. The $1.66 billion on 880 awards is the obligation figure. USAspending.gov indexes those rows as assistance obligations, not outlays.